Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Mrna crawled time : 15:00 save search
RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 3.0%
H: 0.0%
C: -3.43%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.26%
H: 1.04%
C: 0.03%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 1.51%
H: 0.26%
C: -0.72%
SRPT | $116.59 -1.1% -1.12% 500K
|
Health Technology
|
| O: -0.27%
H: 0.54%
C: -0.84%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 0.16%
H: 2.0%
C: 1.42%
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
|
| O: -0.57%
H: 0.35%
C: -1.11%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.17%
H: 0.48%
C: -0.82%
ARWR | $22.62 0.4% 0.4% 1.3M
|
Health Technology
|
| O: 0.16%
H: 0.46%
C: -5.46%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: -0.74%
H: 2.42%
C: -3.47%
therapeutics market
Cellarity Appoints Dr. Gregory J. Moore to Board of Directors
Published: 2023-06-06 (Crawled : 15:00) - biospace.com/
OLK | $22.27 -0.09% -0.09% 890K
|
Manufacturing
|
| O: 0.25%
H: 4.64%
C: 1.33%
OMGA | $2.42 -5.28% -5.58% 360K
|
|
| O: -1.19%
H: 9.8%
C: 4.7%
SANA | $7.74 -6.3% -6.72% 1.9M
|
|
| O: 0.48%
H: 3.68%
C: 1.44%
DVA | $126.11 -1.2% 0.0% 750K
|
Health Services
|
| O: 0.02%
H: 0.83%
C: 0.1%
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -0.21%
H: 3.17%
C: 0.63%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 0.08%
H: 0.12%
C: -1.63%
FHTX | $5.58 -3.46% -3.58% 130K
|
Health Technology
|
| O: 1.24%
H: 2.85%
C: 0.68%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 6.9%
H: 0.81%
C: 0.73%
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: 0.16%
H: 1.47%
C: 0.23%
moore
Senda Biosciences Bolsters Executive Leadership Team
Published: 2022-10-19 (Crawled : 15:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.41%
H: 0.36%
C: -1.82%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -1.19%
H: 0.6%
C: -6.78%
BBIO | $24.98 0.0% 2M
|
Health Technology
|
| O: -1.93%
H: 0.66%
C: -6.37%
New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published: 2022-03-10 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.52%
H: 1.67%
C: 1.67%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
NVAX | $3.9 0.26% 0.26% 2.8M
|
Health Technology
|
| O: -1.99%
H: 2.84%
C: 0.35%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -2.09%
H: 0.95%
C: 0.01%
covid-19 research covid vaccine
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments
Published: 2022-01-25 (Crawled : 15:00) - biospace.com/
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: -3.36%
H: 5.0%
C: 1.74%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.82%
H: 7.85%
C: -2.22%
CRIS | $14.96 -6.21% -6.62% 20K
|
Health Technology
|
| O: -1.53%
H: 1.86%
C: 0.0%
BBIO | $24.98 0.0% 2M
|
Health Technology
|
| O: -0.67%
H: 1.63%
C: -1.54%
ALKS | News | $23.78 -0.96% -0.97% 1.8M
|
Health Technology
|
| O: -0.74%
H: 1.1%
C: -0.71%
biopharma
Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023
Published: 2021-07-22 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.66%
H: 3.32%
C: 1.4%
covid vaccine
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
Published: 2021-06-03 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -1.41%
H: 5.88%
C: 3.35%
covid vaccine covid-19
Worldwide mRNA Vaccines and Therapeutics Industry to 2031 - Featuring Arcturus Therapeutics Holdings, BioNTech and CureVac Among Others
Published: 2021-06-01 (Crawled : 15:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -1.21%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.5%
H: 0.65%
C: 0.32%
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: -5.44%
H: 3.4%
C: 2.71%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.28%
H: 2.56%
C: 0.77%
ARCT 4 | $26.31 -4.81% -5.06% 610K
|
Health Technology
|
| O: 1.3%
H: 1.69%
C: 1.15%
vaccine
CAS launches new brand reflecting strategic evolution to empower smarter science
Published: 2021-04-28 (Crawled : 15:00) - prnewswire.com
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.57%
H: 0.29%
C: -2.02%
First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna’s Next Generation COVID-19 Vaccine
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.16%
H: 5.18%
C: 5.04%
covid phase 1 vaccine phase 3 phase 2 covid-19
Moderna Confirms Discussions with U.S. Government for Additional 100 Million Doses of the Moderna COVID-19 Vaccine
Published: 2021-01-27 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -0.48%
H: 8.83%
C: 3.0%
covid vaccine
Moderna Announces First Participant Dosed in Phase 1/2 Study of Moderna COVID-19 Vaccine in Japan Led by Takeda
Published: 2021-01-21 (Crawled : 15:00) - biospace.com/
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.97%
H: 0.62%
C: -0.63%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 0.11%
H: 9.36%
C: 6.15%
covid vaccine phase 3 phase 1 phase 2
José M. Vega, M.D. Joins Moderna as Chief Safety Officer
Published: 2021-01-12 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 0.57%
H: 5.92%
C: 5.61%
Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines
Published: 2021-01-12 (Crawled : 15:00) - biospace.com/
UBER A | $71.3 -0.89% 0.13% 20M
|
Technology Services
|
| O: 1.67%
H: 7.01%
C: 5.48%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 0.57%
H: 5.92%
C: 5.61%
covid vaccine collaboration covid-19
United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna
Published: 2021-01-08 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 1.24%
H: 1.02%
C: -3.24%
covid vaccine authorized covid-19
Moderna to Provide Business and Pipeline Updates at the 2021 J.P. Morgan Healthcare Conference
Published: 2021-01-04 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 2.64%
H: 5.97%
C: 4.2%
j.p. morgan healthcare conference
European Commission Exercises Option for Additional 80 Million Doses of Moderna’s COVID-19 Vaccine Candidate
Published: 2020-12-18 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -1.73%
H: 2.47%
C: -0.9%
vaccine covid covid-19
Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Adolescents
Published: 2020-12-10 (Crawled : 15:00) - biospace.com/
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: -3.49%
H: 5.54%
C: 3.02%
covid vaccine phase 2 phase 2/3
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.